| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/02/2011 | EP2279166A1 Substituted phenoxybenzamides |
| 02/02/2011 | EP2279008A1 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 02/02/2011 | EP2279006A1 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias |
| 02/02/2011 | EP2279001A1 Inhibitors of gm-csf and il-17 for therapy |
| 02/02/2011 | EP2279000A1 Method for the prevention and treatment of cancer by inhibition of gpvi |
| 02/02/2011 | EP2278976A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors |
| 02/02/2011 | EP2278975A1 Novel nitroso compounds as nitroxyl donors and methods of use thereof |
| 02/02/2011 | EP2278973A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
| 02/02/2011 | EP2278969A2 Inhibitors of janus kinases |
| 02/02/2011 | EP2278966A2 Treatment with opioid antagonists and mtor inhibitors |
| 02/02/2011 | EP1919463B9 Use of hif 1alfa modulators for treatment of cancer |
| 02/02/2011 | EP1805222B1 Antibodies directed to the mammalian eag1 ion channel protein |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN1942473B Process for producing pentacyclic taxane |
| 02/02/2011 | CN1899615B Preparation for the prophylaxis of restenose |
| 02/02/2011 | CN101965366A Immunoconjugates targeting cd138 and uses thereof |
| 02/02/2011 | CN101965351A Benzofuropyrimidinones |
| 02/02/2011 | CN101965350A Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti-cancer agents |
| 02/02/2011 | CN101965349A Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 02/02/2011 | CN101965347A Pyrazolopyridines as kinase inhibitors |
| 02/02/2011 | CN101965342A Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
| 02/02/2011 | CN101965201A Intralymphatic chemotherapy drug carriers |
| 02/02/2011 | CN101965194A Vaccine compositions |
| 02/02/2011 | CN101965191A Improved anticancer treatments |
| 02/02/2011 | CN101962651A L-methionine gamma-lyase gene from deep sea metagenome and expression product thereof |
| 02/02/2011 | CN101962642A Interference RNA for targeting CCP22 gene, medicament composition containing interference RNA and application thereof |
| 02/02/2011 | CN101962602A Health beer made from six Chinese medicinal herbs |
| 02/02/2011 | CN101962415A Method for preparing low molecular weight brown seaweed fucoidan sulfate |
| 02/02/2011 | CN101962405A Humanized breast cancer antigen and antibody thereof |
| 02/02/2011 | CN101962404A Protein used for treating hemangioma |
| 02/02/2011 | CN101962400A Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 02/02/2011 | CN101962398A Separating identification of new compound furostanol saponin in smilacina japonica and antitumor application thereof |
| 02/02/2011 | CN101962381A Alkaloid with anticancer activity and preparation method and application thereof |
| 02/02/2011 | CN101962365A Aminoindazole derivatives as protein-kinase inhibitors |
| 02/02/2011 | CN101962349A 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof |
| 02/02/2011 | CN101961496A Cancerous disease modifying antibodies |
| 02/02/2011 | CN101961494A Star polymer nano-medicament carrier preparation used for intracellular medicament delivery and preparation method thereof |
| 02/02/2011 | CN101961484A Prostate secretory protein 94/57 (Psp94/57), analogous polypeptides thereof for preparing medicaments for eliminating drug (therapy) resistance of tumor, and application thereof |
| 02/02/2011 | CN101961476A Anti-tumor traditional Chinese medicine and preparation method thereof |
| 02/02/2011 | CN101961466A Snake venom capsule for treating cancer |
| 02/02/2011 | CN101961447A Novel preparation method, preparation and application of Chinese medicinal composition |
| 02/02/2011 | CN101961429A Traditional Chinese medicine of camellia nitidissima and berchemia lineate for treating tumors and preparation methods thereof |
| 02/02/2011 | CN101961428A Traditional Chinese medicine for treating tumors by matching fiveleaf gynostemma herb and preparation method thereof |
| 02/02/2011 | CN101961427A Method for extracting polysaccharide and polyphenol of oil-tea camellia husk |
| 02/02/2011 | CN101961395A Chinese traditional medicine for treating tumors by matching with berchemia lineata |
| 02/02/2011 | CN101961394A Traditional Chinese medicine for treating tumors |
| 02/02/2011 | CN101961377A Traditional Chinese medicine for treating tumors by matching linearstripe rabdosia herb |
| 02/02/2011 | CN101961372A Traditional Chinese medicine for treating tumors by matching with Chinese brake herb and preparation method thereof |
| 02/02/2011 | CN101961371A Method for extracting and separating ginsenoside, flavone and polysaccharide from sweet gynostemma pentaphylla |
| 02/02/2011 | CN101961363A Preparation method of active pseudo-ginseng slices |
| 02/02/2011 | CN101961362A Method for preparing active pseudo-ginseng granule |
| 02/02/2011 | CN101961361A Method for preparing active pseudo-ginseng |
| 02/02/2011 | CN101961354A Royal jelly-containing Chinese medicament for treating tumors and preparation method thereof |
| 02/02/2011 | CN101961347A Medicinal composition for treating cancer and use thereof |
| 02/02/2011 | CN101961343A Injection ribonucleic acid and production method thereof |
| 02/02/2011 | CN101961338A Anti-tumor medicine composition |
| 02/02/2011 | CN101961331A Ubiquitin E1 inhibitor and preparation method thereof |
| 02/02/2011 | CN101961122A Recovering beverage for female breast tumor |
| 02/02/2011 | CN101669899B Sustained-release implant taking maize protein as main framework material or matrix and use thereof |
| 02/02/2011 | CN101590035B Application of dehydrogenated silybin in preparing anti-lung-cancer medicament |
| 02/02/2011 | CN101575604B Slow virus vector, preparation thereof and application thereof |
| 02/02/2011 | CN101569654B Application of pigeon pea stilbene acid in the preparation of antitumor drug |
| 02/02/2011 | CN101544952B Oxytropis ehrig cinerea FEL4-OOc and separation method and application thereof |
| 02/02/2011 | CN101513399B Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder |
| 02/02/2011 | CN101468023B Exemestane tablet and technique for preparing the same |
| 02/02/2011 | CN101456890B Specificity inhibitor of leukaemia bcr/abl fusion gene mRNA |
| 02/02/2011 | CN101440073B Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof |
| 02/02/2011 | CN101429175B Perilla alcohol derivant with antineoplastic activity and uses thereof |
| 02/02/2011 | CN101407558B Preparation of Dendrobium nobile polysaccharide extract and use there |
| 02/02/2011 | CN101307041B Novel taxane halogenation derivates with anti-tumor activity |
| 02/02/2011 | CN101278947B Yellow-back fungus fermentation product, composition containing the fermentation product and preparation method thereof |
| 02/02/2011 | CN101270060B 2,6-(amino-benzene methylene)naphthenone compounds, preparation method and application thereof |
| 02/02/2011 | CN101264113B Acanthopanax senticosus effective component and preparation and application |
| 02/02/2011 | CN101260147B Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 02/02/2011 | CN101217966B Combination therapy of cancer with AZD2171 and gemcitabine |
| 02/02/2011 | CN101147732B Application of chlorogenic acid in preparing medicine for preventing and treating nasopharyngeal cancer |
| 02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 02/01/2011 | US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| 02/01/2011 | US7879983 Binding member which binds to both Lewis-y and Lewis-b haptens, and its use for treating cancer |
| 02/01/2011 | US7879981 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879901 Sublingual Formulations of Ketorolac or Salts Thereof |
| 02/01/2011 | US7879881 Piperidinyl compounds that selectively bind integrins |
| 02/01/2011 | US7879868 Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents |
| 02/01/2011 | US7879865 central nervous system disorders; brain cancer; oral administration |
| 02/01/2011 | US7879855 administering (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide, for the treatment of cancers of the colon, lung, ovary, and pancreas; anticarcinogenic agents |
| 02/01/2011 | US7879844 Heterocyclic janus kinase 3 inhibitors |
| 02/01/2011 | US7879823 Topical anti-cancer compositions and methods of use thereof |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879373 comprises curcuminoid and an essential oil of turmeric; curcuminoid mixture consists of curcumin, demethoxycurcumin and bisdemethoxycurcumin and essential oil of turmeric comprises about 45% ar-turmerone |
| 02/01/2011 | US7879364 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 02/01/2011 | US7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 02/01/2011 | US7879327 Treating breast cancer via administration of trastuzumab and amrubicinol |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |